SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasis

Transl Res. 2007 Mar;149(3):103-6. doi: 10.1016/j.trsl.2007.01.003.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Angiogenesis Inhibitors / adverse effects
  • Chronic Disease
  • Humans
  • Indoles / administration & dosage*
  • Indoles / adverse effects
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Pyrroles / administration & dosage*
  • Pyrroles / adverse effects
  • Remission Induction
  • Sunitinib
  • Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Indoles
  • Pyrroles
  • Vascular Endothelial Growth Factor Receptor-2
  • Sunitinib